NEW YORK, April 3, 2022 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors in Zai Lab Limited (“Zai Laboratoryor the “Company”) (NASDAQ: ZLAB). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529 ext. 7980.
The investigation focuses on whether Zai Laboratory and some of its officers and/or directors have engaged in securities fraud or other illegal business practices.
[Click here for information about joining the class action]
At March 9, 2022the United States Securities and Exchange Commission (“SEC”) has issued a notice identifying Zai Laboratoryamong other companies, as in potential violation of the Holding Foreign Companies Accountable Act, which allows the SEC to delist companies and ban trading in a company’s stock if the company does not allow US regulators to review audits of their company for three consecutive years. Zai Laboratory and other companies named in the SEC notification have until March 29, 2022 to challenge the charges against them.
At this news, Zai Lab’s the stock price fell $6.74 per share, or 18.34%, to close at $30.02 per share on March 10, 2022.
Pomerantz LLP, with offices in new York, Chicago, Los Angeles, Parisand Tel Aviv, is recognized as one of the leading law firms in the areas of corporate litigation, securities and antitrust. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues the tradition he established, fighting for the rights of victims of securities fraud, breaches of fiduciary duty and corporate misconduct. The firm recovered numerous multimillion-dollar damages on behalf of class members. See www.pomlaw.com.
Robert S. Willoughby
888-476-6529 ext. 7980
SOURCE Pomerantz LLP